Financial reports
10-Q
2023 Q3
Quarterly report
31 Oct 23
10-Q
2023 Q2
Quarterly report
1 Aug 23
10-Q
2023 Q1
Quarterly report
2 May 23
10-K
2022 FY
Annual report
28 Feb 23
10-Q
2022 Q3
Quarterly report
1 Nov 22
10-Q
2022 Q2
Quarterly report
2 Aug 22
10-Q
2022 Q1
Quarterly report
3 May 22
10-K
2021 FY
Annual report
1 Mar 22
10-Q
2021 Q3
Quarterly report
26 Oct 21
10-Q
2021 Q2
Quarterly report
27 Jul 21
Current reports
8-K
Horizon Technology Finance Provides First Quarter 2024 Portfolio Update
10 Apr 24
8-K
Other Events
27 Feb 24
8-K
Horizon Technology Finance Announces Fourth Quarter and Full Year 2023 Financial Results
27 Feb 24
8-K
Amendments to Articles of Incorporation or Bylaws
26 Feb 24
8-K
Other Events
12 Jan 24
8-K
Horizon Technology Finance Provides Fourth Quarter 2023 Portfolio Update
10 Jan 24
8-K
Other Events
31 Oct 23
8-K
Horizon Technology Finance Announces Third Quarter 2023 Financial Results
31 Oct 23
8-K
Horizon Technology Finance Provides Third Quarter 2023 Portfolio Update
11 Oct 23
8-K
Other Events
22 Sep 23
Registration and prospectus
424B2
Prospectus for primary offering
22 Sep 23
424B2
Prospectus for primary offering
1 Jun 23
424B2
Prospectus for primary offering
30 May 23
8-A12B
Registration of securities on exchange
16 Jun 22
424B2
Prospectus for primary offering
9 Jun 22
FWP
Free writing prospectus
8 Jun 22
424B2
Prospectus for primary offering
8 Jun 22
424B2
Prospectus for primary offering
11 Mar 22
424B2
Prospectus for primary offering
9 Mar 22
424B2
Prospectus for primary offering
2 Aug 21
Proxies
DEF 14A
Definitive proxy
23 Apr 24
DEFA14A
Additional proxy soliciting materials
9 May 23
DEFR14A
Revised proxy
9 May 23
PRER14A
Preliminary revised proxy
3 May 23
DEFA14A
Additional proxy soliciting materials
11 Apr 23
DEFA14A
Additional proxy soliciting materials
6 Apr 23
DEF 14A
Definitive proxy
6 Apr 23
PRE 14A
Preliminary proxy
13 Mar 23
DEFA14A
Additional proxy soliciting materials
1 Mar 23
DEF 14A
Definitive proxy
22 Apr 22
Other
CORRESP
Correspondence with SEC
9 May 23
CORRESP
Correspondence with SEC
6 Apr 23
CERT
Certification of approval for exchange listing
22 Jun 22
EFFECT
Notice of effectiveness
22 Jul 21
CORRESP
Correspondence with SEC
16 Jul 21
CORRESP
Correspondence with SEC
29 Jun 21
CERT
Certification of approval for exchange listing
1 Apr 21
EFFECT
Notice of effectiveness
12 Jul 19
CORRESP
Correspondence with SEC
8 Jul 19
CORRESP
Correspondence with SEC
24 Jun 19
Ownership
4
Gerald A. Michaud
11 Mar 24
3
Evelo Biosciences, Inc.
21 Jul 23
SC 13G
Evelo Biosciences, Inc.
21 Jul 23
3
Michael Balkin
18 Jul 23
3
Jonathan Joseph Goodman
14 Jul 23
3
Lynn Denise Murray Dombrowski
2 Mar 23
3
Kimberley Ann O'Connor
2 Mar 23
4
Gerald A. Michaud
21 Dec 22
4
Robert D. Jr. Pomeroy
12 Dec 22
4
Gerald A. Michaud
7 Dec 22